Reflecting these clinical experiences, EVAR was possibly selected in 20% of rupture cases (representing a 6% increase in relation to the previous year), showing an increasing trend of selection of EVAR as a treatment choice for ruptured AAA cases ( Fig. 2 ).
← all excerpts
Vascular Surgery in Japan: 2012 Annual Report by the Japanese Society for Vascular Surgery.
1
—
—